acetylglucosamine has been researched along with technetium tc 99m-ethylenedicysteine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryant, JL; Chen, J; Ford, RJ; Manyam, GC; Medeiros, LJ; Mendez, R; Pham, LV; Tamayo, AT; Xu-Monette, ZY; Yang, D; Young, KH | 1 |
1 other study(ies) available for acetylglucosamine and technetium tc 99m-ethylenedicysteine
Article | Year |
---|---|
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Apoptosis; Azaserine; Cell Line, Tumor; Cell Proliferation; Contrast Media; Cysteine; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycosylation; Hexosamines; Humans; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred NOD; Mice, SCID; N-Acetylglucosaminyltransferases; NF-kappa B; NFATC Transcription Factors; Organotechnetium Compounds; RNA Interference; RNA, Messenger; RNAi Therapeutics; Signal Transduction; Transfection | 2016 |